Novavax COVID-19 vaccine found to be 89.3% effective in UK trial
Meanwhile, Phase IIb results from South Africa trial demonstrated 60% efficacy - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/novavax_covid-19_vaccine_found_to_be_89.3_effective_in_uk_trial_1362314